You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
陽光諾和(688621.SH):與KNK就SN001和SN002簽署獨家許可協議
格隆匯 05-15 16:41

格隆匯5月15日丨陽光諾和(688621.SH)公佈,公司與KANEKA CORPORATION(簡稱為“KNK”)就SN001(一種用於神經性疾病治療的透皮貼劑)和SN002(一種用於治療精神疾病的透皮貼劑)共同簽署了《許可協議》,KNK將其擁有的上述兩個製劑在中國大陸、香港和澳門的專利獨家授權和技術訣竅的使用授予陽光諾和。

SN001和SN002分別為用於治療神經性疾病及精神疾病的透皮貼劑。與口服制劑相比,透皮貼劑通過穿透皮膚被人體吸收,亦為存在吞嚥困難的病患提供了良好的用藥便捷性,並有望降低噁心、嘔吐等腸胃不良反應的發生率。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account